# Metabo-lipidomics of the Ocular Surface for Cataract Surgery

> **NCT05802550** · NA · COMPLETED · sponsor: **University Hospital, Tours** · enrollment: 100 (actual)

## Conditions studied

- Age-related Cataract

## Interventions

- **OTHER:** Ocular Surface Disease Index
- **OTHER:** Interferometry
- **OTHER:** Oxford score
- **OTHER:** Conjunctival collection
- **OTHER:** Aqueous humor collection
- **OTHER:** Quantification of Tyndall and flare

## Key facts

- **NCT ID:** NCT05802550
- **Lead sponsor:** University Hospital, Tours
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-04
- **Primary completion:** 2025-07-09
- **Final completion:** 2025-07-09
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2026-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05802550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05802550, "Metabo-lipidomics of the Ocular Surface for Cataract Surgery". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT05802550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*